Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors.

J Am Heart Assoc · 2023 · PMC10757508 · PMID 37830344

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Although there was a nominally significant interaction between high‐dose aspirin with double‐dose clopidogrel in the CURRENT‐OASIS 7 trial, the P value for interaction did not meet the prespecified trial threshold of 0.01, suggesting that the interaction may have been attributable to chance.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.